Search results
Pipeline Moves: Phase III completion for Corcept’s relaorilant
Clinical Trials Arena via Yahoo Finance· 34 minutes agoPhase II trial of Regeneron‘s mibavademab completes Regeneron Pharmaceuticals’s mibavademab saw its...
... for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) - ...
Benzinga· 4 hours agoRegeneron Pharmaceuticals, Inc. REGN and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental ...
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock...
Simply Wall St. via Yahoo Finance· 3 days agoKey Insights Institutions' substantial holdings in Regeneron Pharmaceuticals implies that they have...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Merit Financial Group LLC
ETF DAILY NEWS· 4 days agoMerit Financial Group LLC lessened its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 53.7% in the fourth quarter, ...
Regeneron's experimental gene therapy improves hearing in one patient
Reuters via Yahoo News· 5 days ago(Reuters) - Regeneron Pharmaceuticals said on Wednesday its investigational gene therapy improved...
Why Investors Are Eyeing Regeneron Pharmaceuticals Inc (REGN): T
Guru Focus· 7 days agoRegeneron Pharmaceuticals Inc (REGN) has recently captured the attention of investors and financial analysts alike, thanks to its solid financial standing and p
Regeneron’s gene therapy triumphs twice, restoring hearing in children
Clinical Trials Arena via Yahoo Finance· 4 days agoThe two children with rare genetic otoferlin hearing loss enrolled in the Phase I/II trial for...
Weekly Upgrades and Downgrades
InvestorPlace via Yahoo Finance· 7 days agoDuring these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking...
Court Cancels Injunction Hearings In Aflibercept BPCIA Litigation; Regeneron May Seek Temporary...
JD Supra· 3 days agoAs we previously reported, the Judicial Panel on Multidistrict Litigation recently granted Regeneron Pharmaceutical’s (“Regeneron”) motion to establish ...
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Zacks via Yahoo Finance· 3 days agoWhen you look at individual holdings, Neurocrine Biosciences Inc (NBIX) accounts for about 5.26% of...